Stockreport

Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic ... [Yahoo! Finance]

Revvity, Inc.  (RVTY) 
PDF Organic Growth: 3% for the year, within original guidance range. Diagnostic Segment Organic Growth: 7% in Q4. Life Sciences Segment Revenue: $382 million in Q4, fla [Read more]